Cadence Pharmaceuticals – CADX – Announces Termination of Option Agreement to Acquire Incline Therapeutics
Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced that it has entered into an agreement to terminate...